Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

NCT00189176 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Tetrathiomolybdate

Sponsor

University of Michigan

Collaborators

[object Object]